Product

Approved for use in the United States

Please see the Full Prescribing Information including Boxed Warning, information about the FINTEPLA REMS, and the Important Safety Information below.

FINTEPLA (fenfluramine)
Full Prescribing Information including Boxed Warning
Important Safety Information

FINTEPLA.COM
FINTEPLAHCP.COM

You are encouraged to report negative side effects to the FDA. 
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


Approved for use in the European Union, UK, Iceland, Liechtenstein and Norway

Please see the Full Prescribing Information and the Important Safety Information below.

FINTEPLA (fenfluramine)
FINTEPLA.EU

European Public Assessment Report (EPAR)
ema.europa.eu/medicines/human/EPAR/fintepla

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.


If you wish to report an adverse event or make a product complaint, please write to medinfo@zogenix.com or call 1-866-ZOGENIX.